Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr;29(2):363-366.
doi: 10.3350/cmh.2023.0079. Epub 2023 Mar 9.

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise

Moon Haeng Hur  1 , Jeong-Hoon Lee  1
Affiliations
Editorial

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise

Moon Haeng Hur et al. Clin Mol Hepatol. 2023 Apr.
No abstract available

Keywords: Antiviral treatment; Hepatitis B virus; Indolent immune clearance phase; Liver biopsy; Surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

MH Hur has no conflict of interest to disclose. J-H Lee receives research grants from Yuhan Pharmaceuticals and GreenCross Cell, and lecture fees from GreenCross Cell, Daewoong Pharmaceuticals, and Gilead Korea.

Figures

Figure 1.
Figure 1.
Clinical significance of fake IT phase. Patients in the fake IT phase had a higher risk of liver-related events (liver cirrhosis and HCC) than those in the true IT phase. Age, HBV DNA load, platelet count, and serum levels of albumin or AST can be used to suspect the presence of the fake IT phase. AASLD, American Association for the Study of Liver Diseases; ALT, alanine aminotransferase; APASL, Asian Pacific Association for the Study of the Liver; AST, aspartate aminotransferase; EASL, European Association for the Study of the Liver; HCC, hepatocellular carcinoma; IT, immune-tolerant; KASL, Korean Association for the Study of the Liver.
See this image and copyright information in PMC

Comment on

References

    1. Yoon JS, Lee HA, Kim HY, et al. Hepatocellular carcinoma in Korea: an analysis of the 2015 Korean nationwide cancer registry. J Liver Cancer. 2021;21:58–68. - PMC - PubMed
    1. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98. - PMC - PubMed
    1. Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2022;28:276–331. Erratum in: Clin Mol Hepatol 2022;28:940. - PMC - PubMed
    1. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–1599. - PMC - PubMed
    1. European Association for the Study of the Liver EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398. - PubMed

LinkOut - more resources